The prognostic value of tumor budding in invasive breast cancer

Pathology Research and Practice

Volumn 209, Issue 5, 2013, Pages 269-275

  Liang, Fenli ^a,b   Cao, Wei ^c   Wang, Yili ^a   Li, Linrui ^c   Zhang, Guanjun ^a   Wang, Zhuo ^c  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Breast cancer; EMT; Prognosis; Tumor budding

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; UVOMORULIN; VIMENTIN;

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR BUDDING; TUMOR VOLUME;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; CHINA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84878106508     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.01.009     Document Type: Article

References (29)

1. Elston C.W. Grading of invasive carcinoma of the breast. Diagnostic Histopathology of the Breast 1987, 300-311. Churchill Livingstone, Edinburgh. D.L. Page, T.J. Anderson (Eds.).
2. Greco P., Magro G. Comments on the reporting of lymph nodes and tumor budding in the checklist of colorectal carcinoma. Virchows Arch. 2007, 450:359-360.
3. Greene F.L., Page D.L., Fleming I.D., Charles A.F., Balch M., Haller D.G., Morrow M. AJCC Cancer Staging Manual 2002, Springer-Verlag, New York. 6th ed.
4. Hase K., Shatney C., Johnson D., Trollope M., Vierra M. Prognostic value of tumor 'budding' in patients with colorectal cancer. Dis. Colon Rectum 1993, 36:627-635.
5. Hayes B.D., Maguire A., Conlon N., Gibbons D., Wang L.M., Sheahan K. Reproducibility of the rapid bud count method for assessment of tumor budding in stage II colorectal cancer. Am. J. Surg. Pathol. 2010, 34:746-748.
6. Homma Y., Hamano T., Otsuki Y., Shimizu S., Kobayashi H., Kobayashi Y. Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers. J. Surg. Oncol. 2010, 102:230-234.
7. Ishikawa Y., Akishima-Fukasawa Y., Ito K., Akasaka Y., Yokoo T., Ishii T. Toho study group for cancer biological behavior, histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer 2008, 112:924-933.
8. Jass J.R., O'Brien M.J., Riddell R.H., Snover D.C. Association of directors of anatomic and surgical pathology, recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum. Pathol. 2007, 38:537-545.
9. Jouanneau J., Tucker G.C., Boyer B., Valles A.M., Thiery J.P. Epithelial cell plasticity in neoplasia. Cancer Cells 1991, 3:525-529.
10. Kai K., Kohya N., Kitahara K., Masuda M., Miyoshi A., Ide T., Tokunaga O., Miyazaki K., Noshiro H. Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions. Virchows Arch. 2011, 459:449-456.
11. Kanazawa H., Mitomi H., Nishiyama Y., Kishimoto I., Fukui N., Nakamura T., Watanabe M. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis. 2008, 10:41-47.
12. Koike M., Kodera Y., Itoh Y. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann. Surg. Oncol. 2008, 15:1977-1982.
13. Koyuncuoglu M., Okyay E., Saatli B., Olgan S., Akin M., Saygili U. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?. Gynecol. Oncol. 2012, 125:208-213.
14. Lugli A., Karamitopoulou E., Zlobec I. Tumour budding: a promising parameter in colorectal cancer. Br. J. Cancer 2012, 106:1713-1717.
15. Märkl B., Arnholdt H.M. Prognostic significance of tumor budding in gastrointestinal tumors. Expert Rev. Anticancer Ther. 2011, 11:1521-1533.
16. Masugi Y., Yamazaki K., Hibi T., Aiura K., Kitagawa Y., Sakamoto M. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. Hum. Pathol. 2010, 41:1061-1068.
17. Oakman C., Santarpia L., Di Leo A. Breast cancer assessment tools and optimizing adjuvant therapy. Nat. Rev. Clin. Oncol. 2010, 7:725-732.
18. Palmqvist R., Rutegârd J.N., Bozoky B., Landberg G., Stenling R. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am. J. Pathol. 2000, 157:1947-1953.
19. Prall F., Nizze H., Barten M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 2005, 47:17-24.
20. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007, 50:151-162.
21. Rossen P.P. Rosen's breast pathology 2001, Lippncott Williams & Wilkins, Philadelphia, 325-364.
22. Sarioglu S., Acara C., Akman F.C., Dag N., Ecevit C., Ikiz A.O., Cetinayak O.H., Ada E., Dokuz Eylül Head Neck Tumour Group (DEHNTG) Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol. Res. Pract. 2010, 206:88-92.
23. Shinto E., Mochizuki H., Ueno H., Matsubara O., Jass J.R. A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology 2005, 47:25-31.
24. Simon R., Altman D.G. Statistical aspects of prognostic factor studies in oncology. Br. J. Cancer 1994, 69:979-985.
25. Svensson S., Nilsson K., Ringberg A., Landberg G. Invade or proliferate? Two contrasting events in malignant behavior governed by p16 (INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res. 2003, 63:1737-1742.
26. Taira T., Ishii G., Nagai K., Yoh K., Takahashi Y., Matsumura Y., Kojima M., Ohmatsu H., Goto K., Niho S., Takashima H., Inoue H., Ohe Y., Ochiai A. Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung. Lung Cancer 2012, 76:423-430.
27. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
28. Ueno H., Murphy J., Jass J.R., Mochizuki H., Talbot I.C. Tumor 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002, 40:127-132.
29. Zlobec I., Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010, 1:651-661.